• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四氢蝶呤在治疗因四氢生物蝶呤合成缺陷所致高苯丙氨酸血症中的应用:外周给予的四氢蝶呤进入脑内的证据

Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: evidence that peripherally administered tetrahydropterins enter the brain.

作者信息

Kaufman S, Kapatos G, McInnes R R, Schulman J D, Rizzo W B

出版信息

Pediatrics. 1982 Sep;70(3):376-80.

PMID:7110811
Abstract

Substantial amounts of tetrahydrobiopterin and 6-methyltetrahydropterin can be detected in CSF when these pterins are given peripherally to patients with hyperphenylalaninemia due to defective biopterin synthesis. Results of this study suggest that administration of either of these pterins in proper doses may prove to be a treatment not only for the impaired peripheral phenylalanine metabolism, but also for the neurologic disorders that are characteristic of the variant forms of hyperphenylalaninemia due to defective tetrahydrobiopterin synthesis or metabolism.

摘要

当将这些蝶呤经外周给予因蝶呤合成缺陷导致高苯丙氨酸血症的患者时,可在脑脊液中检测到大量的四氢生物蝶呤和6 - 甲基四氢蝶呤。本研究结果表明,以适当剂量给予这两种蝶呤中的任何一种,可能不仅被证明是治疗外周苯丙氨酸代谢受损的方法,而且也是治疗因四氢生物蝶呤合成或代谢缺陷导致的高苯丙氨酸血症变异形式所特有的神经障碍的方法。

相似文献

1
Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: evidence that peripherally administered tetrahydropterins enter the brain.四氢蝶呤在治疗因四氢生物蝶呤合成缺陷所致高苯丙氨酸血症中的应用:外周给予的四氢蝶呤进入脑内的证据
Pediatrics. 1982 Sep;70(3):376-80.
2
Tetrahydropterin therapy for hyperphenylalaninemia caused by defective synthesis of tetrahydrobiopterin.四氢生物蝶呤疗法用于治疗因四氢生物蝶呤合成缺陷引起的高苯丙氨酸血症。
Ann Neurol. 1983 Sep;14(3):308-15. doi: 10.1002/ana.410140309.
3
Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man.伴有生物蝶呤代谢缺陷的非典型苯丙酮尿症。四氢生物蝶呤或司来吉兰单药治疗、人体生物合成的筛查与研究。
Eur J Pediatr. 1982 Mar;138(2):110-2. doi: 10.1007/BF00441135.
4
Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin.生物蝶呤合成缺陷。左旋多巴和5-羟色氨酸治疗与四氢生物蝶呤治疗的比较
J Clin Invest. 1984 Feb;73(2):458-69. doi: 10.1172/JCI111232.
5
Biopterin synthesis defects: problems in diagnosis.生物蝶呤合成缺陷:诊断中的问题。
Pediatrics. 1984 Dec;74(6):1004-11.
6
Study of tetrahydrobiopterin and 6-methyltetrahydropterin on alcohol dependence in mice.
Res Commun Chem Pathol Pharmacol. 1983 Oct;42(1):107-12.
7
Peripherally administered reduced pterins do enter the brain.经外周给药的还原蝶呤确实会进入大脑。
Science. 1981 May 22;212(4497):955-6. doi: 10.1126/science.7233193.
8
Combined tetrahydrobiopterin-phenylalanine loading test in the detection of partially defective biopterin synthesis.联合四氢生物蝶呤-苯丙氨酸负荷试验在检测部分缺陷性生物蝶呤合成中的应用
Eur J Pediatr. 1984 Jun;142(2):126-9. doi: 10.1007/BF00445592.
9
Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria.由于生物蝶呤缺乏导致的高苯丙氨酸血症。苯丙酮尿症的一种变异形式。
N Engl J Med. 1978 Sep 28;299(13):673-9. doi: 10.1056/NEJM197809282991301.
10
[Malignant hyperphenylalaninemia--tetrahydrobiopterin (BH4) deficiency].[恶性高苯丙氨酸血症——四氢生物蝶呤(BH4)缺乏症]
Tanpakushitsu Kakusan Koso. 1988 Apr;33(5):493-6.

引用本文的文献

1
Evaluation of Tetrahydrobiopterin Therapy with Large Neutral Amino Acid Supplementation in Phenylketonuria: Effects on Potential Peripheral Biomarkers, Melatonin and Dopamine, for Brain Monoamine Neurotransmitters.苯丙酮尿症中补充大中性氨基酸的四氢生物蝶呤疗法评估:对脑单胺神经递质潜在外周生物标志物褪黑素和多巴胺的影响。
PLoS One. 2016 Aug 11;11(8):e0160892. doi: 10.1371/journal.pone.0160892. eCollection 2016.
2
High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU).高剂量盐酸沙丙蝶呤疗法可改善小鼠苯丙酮尿症(PKU)中的单胺神经递质周转。
Mol Genet Metab. 2016 Jan;117(1):5-11. doi: 10.1016/j.ymgme.2015.11.012. Epub 2015 Nov 26.
3
Dihydropteridine reductase deficiency and treatment with tetrahydrobiopterin: a case report.
二氢蝶啶还原酶缺乏症及四氢生物蝶呤治疗:一例报告
JIMD Rep. 2013;10:53-6. doi: 10.1007/8904_2012_202. Epub 2012 Dec 29.
4
Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?哪些神经保护剂已准备好在新生儿中从实验室转化到临床应用?
J Pediatr. 2012 Apr;160(4):544-552.e4. doi: 10.1016/j.jpeds.2011.12.052. Epub 2012 Feb 9.
5
Tetrahydrobiopterin as a novel therapeutic intervention for autism.四氢生物蝶呤作为自闭症治疗的新方法。
Neurotherapeutics. 2010 Jul;7(3):241-9. doi: 10.1016/j.nurt.2010.05.004.
6
Disorders of biopterin metabolism.生物蝶呤代谢紊乱。
J Inherit Metab Dis. 2009 Jun;32(3):333-42. doi: 10.1007/s10545-009-1067-2. Epub 2009 Feb 9.
7
Possible high frequency of tetrahydrobiopterin deficiency in south Brazil.
J Inherit Metab Dis. 1994;17(2):223-9. doi: 10.1007/BF00711622.
8
Cerebrospinal fluid biopterin and biogenic amine metabolites during oral R-THBP therapy for infantile autism.
J Autism Dev Disord. 1995 Apr;25(2):183-93. doi: 10.1007/BF02178503.
9
Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin.生物蝶呤合成缺陷。左旋多巴和5-羟色氨酸治疗与四氢生物蝶呤治疗的比较
J Clin Invest. 1984 Feb;73(2):458-69. doi: 10.1172/JCI111232.
10
Neurological aspects of biopterin metabolism.生物蝶呤代谢的神经学方面。
Arch Dis Child. 1986 Feb;61(2):130-7. doi: 10.1136/adc.61.2.130.